Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > marc cohodes
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by WillyWallyon May 13, 2016 10:23am
145 Views
Post# 24869935

RE:RE:RE:RE:marc cohodes

RE:RE:RE:RE:marc cohodes40-48 would never go through approval, and if it did the management would be covered in lawsuits. 

Zerosum wrote: The reason the share price is where it is ... it's going private. In short the cheaper the share price the better for the buyers. In a few years 1-3 re-list at $75.00 or $100.00 or higher. expect 40-48 now.  
Then again I could be wrong.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities